Ionis Pharmaceuticals
Stock Forecast, Prediction & Price Target
Ionis Pharmaceuticals Financial Estimates
Ionis Pharmaceuticals Revenue Estimates
Ionis Pharmaceuticals EBITDA Estimates
Ionis Pharmaceuticals Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $810M N/A | $587M -27.53% | $787.64M 34.18% | Avg: $748.01M Low: $748.01M High: $748.01M avg. -5.03% | Avg: $1.03B Low: $1.03B High: $1.03B avg. 38.79% | Avg: $1.29B Low: $1.29B High: $1.29B avg. 25.03% | Avg: $1.67B Low: $1.67B High: $1.67B avg. 29.12% |
Net Income
% change YoY
| $-29M N/A | $-270M -831.03% | $-366.28M -35.66% | Avg: $-472.90M Low: $-472.90M High: $-472.90M avg. -29.10% | Avg: $-275.31M Low: $-275.31M High: $-275.31M avg. 41.78% | Avg: $-91.63M Low: $-91.63M High: $-91.63M avg. 66.71% | Avg: $148.05M Low: $148.05M High: $148.05M avg. 261.58% |
EBITDA
% change YoY
| $-21M N/A | $-561M -2571.42% | $-230.01M 59% | Avg: $-194.71M Low: $-194.71M High: $-194.71M avg. 15.34% | Avg: $-270.25M Low: $-270.25M High: $-270.25M avg. -38.79% | Avg: $-337.90M Low: $-337.90M High: $-337.90M avg. -25.03% | Avg: $-436.32M Low: $-436.32M High: $-436.32M avg. -29.12% |
EPS
% change YoY
| -$0.21 N/A | -$1.9 -804.76% | -$2.56 -34.73% | Avg: -$3.3 Low: -$3.3 High: -$3.3 avg. -29.00% | Avg: -$1.92 Low: -$1.92 High: -$1.92 avg. 41.78% | Avg: -$0.64 Low: -$0.64 High: -$0.64 avg. 66.71% | Avg: $1.03 Low: $1.03 High: $1.03 avg. 261.58% |
Operating Expenses
% change YoY
| $829M N/A | $984M 18.69% | $1.13B 15.06% | Avg: $227.89M Low: $227.89M High: $227.89M avg. -79.87% | Avg: $316.30M Low: $316.30M High: $316.30M avg. 38.79% | Avg: $395.48M Low: $395.48M High: $395.48M avg. 25.03% | Avg: $510.68M Low: $510.68M High: $510.68M avg. 29.12% |
FAQ
What is Ionis Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 85.24% in 2025-2028.
We have gathered data from N/A analysts. Their low estimate is -472.90M, average is -472.90M and high is -472.90M.
What is Ionis Pharmaceuticals stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 21.98% in 2025-2028.
We have gathered data from N/A analysts. Their low revenue estimate is $748.01M, average is $748.01M and high is $748.01M.
What is Ionis Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 85.26% in 2025-2028.
We have gathered data from N/A analysts. Their low earnings per share estimate is -$3.3, average is -$3.3 and high is $-3.30.